These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 24681001)

  • 21. T-cells in multiple sclerosis.
    Severson C; Hafler DA
    Results Probl Cell Differ; 2010; 51():75-98. PubMed ID: 19582415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-based modulation of autoimmune responses in multiple sclerosis and experimental autoimmmune encephalomyelitis: therapeutic implications.
    Mastorodemos V; Ioannou M; Verginis P
    Neuroimmunomodulation; 2015; 22(3):181-95. PubMed ID: 24852748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of dendritic cells in CNS autoimmunity.
    Zozulya AL; Clarkson BD; Ortler S; Fabry Z; Wiendl H
    J Mol Med (Berl); 2010 Jun; 88(6):535-44. PubMed ID: 20217033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection from autoimmunity by DNA vaccination against T-cell receptor.
    Buch T; Waisman A
    Methods Mol Med; 2006; 127():269-80. PubMed ID: 16988460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis.
    van Zwam M; Huizinga R; Heijmans N; van Meurs M; Wierenga-Wolf AF; Melief MJ; Hintzen RQ; 't Hart BA; Amor S; Boven LA; Laman JD
    J Pathol; 2009 Mar; 217(4):543-51. PubMed ID: 19023878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system.
    Prinz M; Schmidt H; Mildner A; Knobeloch KP; Hanisch UK; Raasch J; Merkler D; Detje C; Gutcher I; Mages J; Lang R; Martin R; Gold R; Becher B; Brück W; Kalinke U
    Immunity; 2008 May; 28(5):675-86. PubMed ID: 18424188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokines and effector T cell subsets causing autoimmune CNS disease.
    Petermann F; Korn T
    FEBS Lett; 2011 Dec; 585(23):3747-57. PubMed ID: 21477588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis.
    Miller SD; McMahon EJ; Schreiner B; Bailey SL
    Ann N Y Acad Sci; 2007 Apr; 1103():179-91. PubMed ID: 17376826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
    Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An autoimmunity odyssey: how autoreactive T cells infiltrate into the CNS.
    Kawakami N; Bartholomäus I; Pesic M; Mues M
    Immunol Rev; 2012 Jul; 248(1):140-55. PubMed ID: 22725959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The contribution of neutrophils to CNS autoimmunity.
    Pierson ER; Wagner CA; Goverman JM
    Clin Immunol; 2018 Apr; 189():23-28. PubMed ID: 27377536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Green tea EGCG, T cells, and T cell-mediated autoimmune diseases.
    Wu D; Wang J; Pae M; Meydani SN
    Mol Aspects Med; 2012 Feb; 33(1):107-18. PubMed ID: 22020144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain.
    Becher B; Bechmann I; Greter M
    J Mol Med (Berl); 2006 Jul; 84(7):532-43. PubMed ID: 16773356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation.
    Haylock-Jacobs S; Comerford I; Bunting M; Kara E; Townley S; Klingler-Hoffmann M; Vanhaesebroeck B; Puri KD; McColl SR
    J Autoimmun; 2011 May; 36(3-4):278-87. PubMed ID: 21396797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New lessons about old molecules: how type I interferons shape Th1/Th17-mediated autoimmunity in the CNS.
    Prinz M; Kalinke U
    Trends Mol Med; 2010 Aug; 16(8):379-86. PubMed ID: 20591737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications.
    Dos Passos GR; Sato DK; Becker J; Fujihara K
    Mediators Inflamm; 2016; 2016():5314541. PubMed ID: 26941483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic cells in central nervous system autoimmunity.
    Sie C; Korn T
    Semin Immunopathol; 2017 Feb; 39(2):99-111. PubMed ID: 27888330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex differences regulate immune responses in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Ryan L; Mills KHG
    Eur J Immunol; 2022 Jan; 52(1):24-33. PubMed ID: 34727577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The contribution of gammadelta T cells to the pathogenesis of EAE and MS.
    Blink SE; Miller SD
    Curr Mol Med; 2009 Feb; 9(1):15-22. PubMed ID: 19199938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.